Ciproflexacin-loaded polyisobutylcyanoacrylate nanoparticles: Preparation and characterization

[1]  P. Couvreur,et al.  Molecular Weights of Free and Drug-Loaded Nanoparticles , 2004, Pharmaceutical Research.

[2]  G. Cavallaro,et al.  Pefloxacine mesilate- and ofloxacin-loaded polyethylcyanoacrylate nanoparticles: characterization of the colloidal drug carrier formulation. , 1995, Journal of pharmaceutical sciences.

[3]  G. Cavallaro,et al.  Entrapment of β-lactams antibiotics in polyethylcyanoacrylate nanoparticles: Studies on the possible in vivo application of this colloidal delivery system , 1994 .

[4]  M. Fresta,et al.  Association of netilmicin Sulphate to poly(Alkylcyanoacrylate) Nanoparticles: Factors Influencing particle delivery Behaviour , 1994 .

[5]  J. Fierer,et al.  Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis , 1993, Antimicrobial Agents and Chemotherapy.

[6]  M. R. Aberturas,et al.  Formation and characterization of cyclosporine-loaded nanoparticles. , 1993, Journal of pharmaceutical sciences.

[7]  D. Friend,et al.  Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages , 1992, Antimicrobial Agents and Chemotherapy.

[8]  Rainer H. Müller,et al.  Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length , 1992 .

[9]  M. Boroujerdi,et al.  Uptake capacity and adsorption isotherms of doxorubicin on polymeric nanoparticles: effect of methods of preparation , 1992 .

[10]  P. Couvreur,et al.  Adsorption of hematoporphyrin onto polyalkylcyanoacrylate nanoparticles: carrier capacity and drug release , 1991 .

[11]  V. Préat,et al.  Nanoparticles of Polyisohexylcyanoacrylate (pihca) As Carriers of Primaquine - Formulation, Physicochemical Characterization and Acute Toxicity , 1991 .

[12]  M. Alonso,et al.  Approaches to improve the association of amikacin sulphate to poly(alkylcyanoacrylate) nanoparticles , 1991 .

[13]  C. Riley,et al.  Aqueous solubilities of some variously substituted quinolone antimicrobials , 1990 .

[14]  P. Couvreur,et al.  Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles , 1989, Antimicrobial Agents and Chemotherapy.

[15]  P. Couvreur,et al.  Effectiveness of nanoparticle-bound ampicillin in the treatment of Listeria monocytogenes infection in athymic nude mice , 1988, Antimicrobial Agents and Chemotherapy.

[16]  N. Georgopapadakou,et al.  Routes of quinolone permeation in Escherichia coli , 1988, Antimicrobial Agents and Chemotherapy.

[17]  P. Couvreur,et al.  Attachment of antibiotics to nanoparticles: preparation, drug-release and antimicrobial activity in vitro , 1987 .

[18]  D. Guay,et al.  Determination of ciprofloxacin and its 7-ethylenediamine metabolite in human serum and urine by high-performance liquid chromatography. , 1987, Journal of chromatography.

[19]  R. Lenk,et al.  Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides. , 1985, The Journal of infectious diseases.

[20]  I. Bakker-Woudenberg,et al.  Free versus liposome-entrapped ampicillin in treatment of infection due to Listeria monocytogenes in normal and athymic (nude) mice. , 1985, The Journal of infectious diseases.

[21]  S. Davis,et al.  Particle size and size distribution of poly(butyl-2-cyanoacrylate) nanoparticles: I. Influence of physicochemical factors , 1984 .

[22]  M. Stevenson,et al.  Enhanced activity of streptomycin and chloramphenicol against intracellular Escherichia coli in the J774 macrophage cell line mediated by liposome delivery , 1983, Antimicrobial Agents and Chemotherapy.

[23]  Desiderio Jv,et al.  Liposome-encapsulated cephalothin in the treatment of experimental murine salmonellosis. , 1983 .

[24]  S. G. Campbell,et al.  Intraphagocytic killing of Salmonella typhimurium by liposome-encapsulated cephalothin. , 1983, The Journal of infectious diseases.